We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
112 hedge funds and large institutions have $478M invested in Oric Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 55 increasing their positions, 18 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
206% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 18
5.31% more ownership
Funds ownership: 94.92% → 100.23% (+5.3%)
5% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 20
0% more funds holding
Funds holding: 112 → 112 (0)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
46% less capital invested
Capital invested by funds: $879M → $478M (-$402M)
Holders
112
Holders Change
–
Holders Change %
0%
% of All Funds
1.62%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
21
Increased
55
Reduced
18
Closed
20
Calls
$51K
Puts
–
Net Calls
+$51K
Net Calls Change
-$3.08M
Top Buyers
| 1 |
BlackRock
New York
|
+$14.8M |
| 2 |
Millennium Management
New York
|
+$5.24M |
| 3 |
State Street
Boston,
Massachusetts
|
+$4.84M |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$3.76M |
| 5 |
FTM
First Turn Management
Del Mar,
California
|
+$3.75M |
